2020
DOI: 10.3390/molecules25132991
|View full text |Cite
|
Sign up to set email alerts
|

Curcumin Containing PEGylated Solid Lipid Nanoparticles for Systemic Administration: A Preliminary Study

Abstract: Curcumin (CUR) has a wide range of pharmacological properties, including anti-inflammatory and antioxidant activities, and it can be considered a good candidate for the potential treatment of central nervous system (CNS) pathologies, although its use in clinical practice is compromised due to its high lipophilicity. Solid lipid nanoparticles (SLNs) are well-known nanocarriers representing a consolidated approach for the delivery of lipophilic compounds, but their systemic use is limited due their short… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
20
0
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 31 publications
(23 citation statements)
references
References 56 publications
2
20
0
1
Order By: Relevance
“…Cur-PNP and Cur-SLN were cryoprotected with glucose being a suitable excipient for both lipid and polymeric nanosuspensions [ 77 , 78 ].…”
Section: Resultsmentioning
confidence: 99%
“…Cur-PNP and Cur-SLN were cryoprotected with glucose being a suitable excipient for both lipid and polymeric nanosuspensions [ 77 , 78 ].…”
Section: Resultsmentioning
confidence: 99%
“…Santonocito et al prepared functionalized curcumin-loaded SLNs by solvent emulsification/evaporation technique for the systemic administration of curcumin [ 81 ]. Curcumin, Compritol 888 ATO and injectable soy lecithin were solubilized and melted in ethanol at 70 °C.…”
Section: Preparation Methods and Functionalization Approachesmentioning
confidence: 99%
“…Curcumin, Compritol 888 ATO and injectable soy lecithin were solubilized and melted in ethanol at 70 °C. The melted lipid phase was dispersed in the hot surfactant solution (Lutrol F68) under stirring and then this solution was cooled in an ice bath and the organic solvent was removed by vacuum [ 81 ]. Small particles sizes can be obtained using this methodology due to the good solubilization of the lipid in the organic solvent, with the absence of any thermal stress or heat being a great advantage towards HPH.…”
Section: Preparation Methods and Functionalization Approachesmentioning
confidence: 99%
See 1 more Smart Citation
“…The use of antioxidant compounds for the management of neurodegenerative diseases is mainly limited by poor bioavailability, enzymatic degradation and scarce BBB crossing [ 14 , 15 ]. To overcome these issues, nanovectors for the delivery of antioxidants and inorganic nanoparticles (NPs) as free radical scavenger themselves have been proposed [ 14 , 16 , 17 , 18 ].…”
Section: Introductionmentioning
confidence: 99%